Results 241 to 250 of about 1,426,705 (304)

Understanding and Overcoming Antibody‐Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer

Advanced Science, EarlyView.
Antibody–drug conjugates (ADCs) transform breast cancer therapy, yet resistance limits their durability. Emerging evidence reveals that ADC failure is not solely tumor‐intrinsic but shaped by dynamic tumor–microenvironment interactions that alter drug delivery, processing, and response.
Minji Seo, Jangsoon Lee, Naoto T. Ueno
wiley   +1 more source

Overall survival outcomes in occult primary breast cancer. [PDF]

Breast
Tashjian NL, Day C, Boughey JC, Piltin MA.   +3 more
europepmc   +1 more source

Topology-Based Biomarkers Accurately Predict Breast Cancer Outcome and Survival. [PDF]

Cancer Res
Singhal S, Li C, Aukerman A, Carrière M, Miller ML, Hibshoosh H, McDonald JA, Winfield JR, Aung STH, Martinez-Delgado G, Frankenstein Z, Lee YH, Rabadan R, Saltz J, Chen C, Gardner K.   +15 more
europepmc   +1 more source

Breast Cancer and Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]

Int J Mol Sci
Nieva-Ramírez DG, Luna-Pérez D, Uribe M, Nuño-Lámbarri N.   +3 more
europepmc   +1 more source

The Role of Lipid Metabolism in the Progression of Breast Cancer. [PDF]

J Cancer
Liu TT, Wang MM.
europepmc   +1 more source